0001035267-24-000122.txt : 20240311
0001035267-24-000122.hdr.sgml : 20240311
20240311201127
ACCESSION NUMBER: 0001035267-24-000122
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240308
FILED AS OF DATE: 20240311
DATE AS OF CHANGE: 20240311
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DeSantis Robert
CENTRAL INDEX KEY: 0001808942
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-30713
FILM NUMBER: 24739867
MAIL ADDRESS:
STREET 1: C/O INTUITIVE SURGICAL, INC.
STREET 2: 1020 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: INTUITIVE SURGICAL INC
CENTRAL INDEX KEY: 0001035267
STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 770416458
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1020 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
BUSINESS PHONE: 4085232100
MAIL ADDRESS:
STREET 1: 1020 KIFER ROAD
CITY: SUNNYVALE
STATE: CA
ZIP: 94086
4
1
edgardoc.xml
PRIMARY DOCUMENT
X0508
4
2024-03-08
0
0001035267
INTUITIVE SURGICAL INC
ISRG
0001808942
DeSantis Robert
1020 KIFER ROAD
SUNNYVALE
CA
94086
0
1
0
0
EVP & Chief Strategy & Corp Op
1
Common Stock
2024-03-08
4
M
0
1504
290.33
A
12579
D
Common Stock
2024-03-08
4
S
0
1504
393.808
D
11075
D
Common Stock
2024-03-08
4
M
0
7149
347.4167
A
18224
D
Common Stock
2024-03-08
4
S
0
7149
393.775
D
11075
D
Common Stock
2024-03-08
4
M
0
993
245.6
A
12068
D
Common Stock
2024-03-08
4
S
0
993
393.8026
D
11075
D
Common Stock
2024-03-08
4
M
0
453
242.3367
A
11528
D
Common Stock
2024-03-08
4
S
0
453
393.8026
D
11075
D
Common Stock
2024-03-08
4
M
0
363
179.7
A
11438
D
Common Stock
2024-03-08
4
S
0
363
393.7969
D
11075
D
Common Stock
2024-03-08
4
M
0
453
177.9867
A
11528
D
Common Stock
2024-03-08
4
S
0
453
393.7969
D
11075
D
Common Stock
2024-03-08
4
M
0
1437
304.67
A
12512
D
Common Stock
2024-03-08
4
S
0
1437
393.802
D
11075
D
Common Stock
2024-03-08
4
M
0
1436
229.39
A
12511
D
Common Stock
2024-03-08
4
S
0
1436
393.8164
D
11075
D
Common Stock
2024-03-08
4
M
0
940
208.9
A
12015
D
Common Stock
2024-03-08
4
S
0
940
393.8164
D
11075
D
Common Stock
2024-03-08
4
S
0
2819
393.7942
D
8256
D
Common Stock
2024-03-08
4
S
0
2749
393.8309
D
5507
D
Common Stock
2024-03-11
4
M
0
90
179.7
A
5597
D
Common Stock
2024-03-11
4
S
0
90
390.16
D
5507
D
Common Stock
2024-03-11
4
M
0
119
304.67
A
5626
D
Common Stock
2024-03-11
4
S
0
119
390.16
D
5507
D
Common Stock
2024-03-11
4
M
0
120
229.39
A
5627
D
Common Stock
2024-03-11
4
S
0
120
390.16
D
5507
D
Non-Qualified Stock Option (right to buy)
177.9867
2024-03-08
4
M
0
453
0.0
D
2030-02-28
Common Stock
453
0
D
Non-Qualified Stock Option (right to buy)
179.7
2024-03-08
4
M
0
363
0.0
D
2030-05-11
Common Stock
363
270
D
Non-Qualified Stock Option (right to buy)
179.7
2024-03-11
4
M
0
90
0.0
D
2030-05-11
Common Stock
90
180
D
Non-Qualified Stock Option (right to buy)
208.9
2024-03-08
4
M
0
940
0.0
D
2029-08-28
Common Stock
940
4511
D
Non-Qualified Stock Option (right to buy)
229.39
2024-03-08
4
M
0
1436
0.0
D
2030-02-27
Common Stock
1436
4310
D
Non-Qualified Stock Option (right to buy)
229.39
2024-03-11
4
M
0
120
0.0
D
2030-02-27
Common Stock
120
4190
D
Non-Qualified Stock Option (right to buy)
242.3367
2024-03-08
4
M
0
453
0.0
D
2030-08-28
Common Stock
453
0
D
Non-Qualified Stock Option (right to buy)
245.6
2024-03-08
4
M
0
993
0.0
D
2031-02-26
Common Stock
993
2382
D
Non-Qualified Stock Option (right to buy)
290.33
2024-03-08
4
M
0
1504
0.0
D
2029-02-28
Common Stock
1504
4512
D
Non-Qualified Stock Option (right to buy)
304.67
2024-03-08
4
M
0
1437
0.0
D
2030-08-09
Common Stock
1437
4309
D
Non-Qualified Stock Option (right to buy)
304.67
2024-03-11
4
M
0
119
0.0
D
2030-08-09
Common Stock
119
4190
D
Non-Qualified Stock Option (right to buy)
347.4167
2024-03-08
4
M
0
7149
0.0
D
2031-08-26
Common Stock
7149
2382
D
These shares were sold in accordance with a Trading Plan that complies with SEC Rule 10b5-1 and expires on December 9, 2024.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 327 shares sold at $391.89 to $392.02; 1,077 shares sold at $393.73 to $394.61; and 100 shares sold at $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.05 as follows: 1,277 shares sold at $391.89 to $392.02; 157 shares sold at $392.50 to $392.52; 4,145 shares sold at $393.53 to $394.53; and 1,570 shares sold at $394.56 to $395.05. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.00 as follows: 318 shares sold at $391.89 to $392.02; 1,028 shares sold at $393.72 to $394.61; and 100 shares sold at $395.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.80 as follows: 223 shares sold at $391.89 to $392.02 and 593 shares sold at $394.00 to $394.80. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.00 as follows: 317 shares sold at $391.89 to $392.02; 1,020 shares sold at $393.72 to $394.61; and 100 shares sold at $395.00. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $395.32 as follows: 458 shares sold at $391.89 to $392.02; 780 shares sold at $393.22 to $394.14; 1,134 shares sold at $394.27 to $394.82; and 4 shares sold at $395.32. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 525 shares sold at $391.89 to $392.02; 1,876 shares sold at $393.55 to $394.53; and 418 shares sold at $394.60 to $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $391.89 to $394.82 as follows: 515 shares sold at $391.89 to $392.02; 2,034 shares sold at $393.65 to $394.61; and 200 shares sold at $394.60 to $394.82. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The option vests 1/8th six months after the date of grant and 1/48th monthly thereafter.
Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. The grant vests 25% on the first anniversary of the date of grant and monthly thereafter, over a four year period of time.
Non-statutory stock option granted pursuant to the 2010 Incentive Award Plan. Option shall vest 7/48 one month after the date of grant and 1/48 each month thereafter.
12.5% of the shares subject to the option vest on the six-month anniversary measured from February 10, 2023, and 1/48th of the total number of shares vest in forty-two (42) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
7/48th of the shares subject to the option vest on the one-month anniversary measured from August 10, 2023, and 1/48th of the total number of shares vest in forty-one (41) successive and equal monthly installments thereafter, subject to Reporting Person's continuous service to the Issuer through each such vesting date.
By: Donna Spinola For: DeSantis, Robert
2024-03-11